Perrigo Company plc Amortization of Intangible Assets
Perrigo Company plc (PRGO) reported Amortization of Intangible Assets of $54.50 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-05
- Perrigo Company plc amortization of intangible assets for the quarter ending 2026-06-27 was $54.50M, a 3.71% decline year-over-year.
- Perrigo Company plc amortization of intangible assets for the quarter ending 2026-03-28 was $54.50M, a 0.55% decline year-over-year.
- Perrigo Company plc amortization of intangible assets for the quarter ending 2025-12-31 was $55.50M, a 0.73% increase year-over-year.
- Perrigo Company plc amortization of intangible assets for the quarter ending 2025-09-27 was $55.80M, a 2.96% decline year-over-year.
- Perrigo Company plc amortization of intangible assets for fiscal 2025 was $222.70M, a 2.54% decline from fiscal 2024.
- Perrigo Company plc amortization of intangible assets for fiscal 2024 was $228.50M, a 14.03% decline from fiscal 2023.
- Perrigo Company plc amortization of intangible assets for fiscal 2023 was $265.80M, a 5.31% increase from fiscal 2022.
- Perrigo Company plc amortization of intangible assets for fiscal 2022 was $252.40M, a 20.19% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $54.50M 10-Q · filed 2026-08-05 | $109.00M 10-Q · filed 2026-08-05 | $164.50M derived: sum of 3 quarters · filed 2026-08-05 | $220.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | $54.50M 10-Q · filed 2026-05-06 | $110.00M derived: sum of 2 quarters · filed 2026-05-06 | $165.80M derived: sum of 3 quarters · filed 2026-05-06 | $222.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $55.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $111.30M derived: sum of 2 quarters · filed 2026-02-26 | $167.90M derived: sum of 3 quarters · filed 2026-08-05 | $222.70M 10-K · filed 2026-02-26 | ||||
| 2025-09-27 | $55.80M 10-Q · filed 2025-11-05 | $112.40M derived: sum of 2 quarters · filed 2026-08-05 | $167.20M 10-Q · filed 2025-11-05 | $222.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | $56.60M 10-Q · filed 2026-08-05 | $111.40M 10-Q · filed 2026-08-05 | $166.50M derived: sum of 3 quarters · filed 2026-08-05 | $224.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | $54.80M 10-Q · filed 2026-05-06 | $109.90M derived: sum of 2 quarters · filed 2026-05-06 | $167.40M derived: sum of 3 quarters · filed 2026-05-06 | $224.90M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $55.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $112.60M derived: sum of 2 quarters · filed 2026-02-26 | $170.10M derived: sum of 3 quarters · filed 2026-02-26 | $228.50M 10-K · filed 2026-02-26 | ||||
| 2024-09-28 | $57.50M 10-Q · filed 2025-11-05 | $115.00M derived: sum of 2 quarters · filed 2025-11-05 | $173.40M 10-Q · filed 2025-11-05 | $236.50M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-29 | $57.50M 10-Q · filed 2025-08-06 | $115.90M 10-Q · filed 2025-08-06 | $179.00M derived: sum of 3 quarters · filed 2026-02-26 | $247.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-30 | $58.40M 10-Q · filed 2025-05-07 | $121.50M derived: sum of 2 quarters · filed 2026-02-26 | $189.50M derived: sum of 3 quarters · filed 2026-02-26 | $258.80M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $63.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $131.10M derived: sum of 2 quarters · filed 2026-02-26 | $200.40M derived: sum of 3 quarters · filed 2026-02-26 | $265.80M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $68.00M 10-Q · filed 2024-11-06 | $137.30M derived: sum of 2 quarters · filed 2024-11-06 | $202.70M 10-Q · filed 2024-11-06 | $276.30M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-07-01 | $69.30M 10-Q · filed 2024-08-02 | $134.70M 10-Q · filed 2024-08-02 | $208.30M derived: sum of 3 quarters · filed 2025-02-28 | $276.20M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-04-01 | $65.40M 10-Q · filed 2024-05-07 | $139.00M derived: sum of 2 quarters · filed 2025-02-28 | $206.90M derived: sum of 3 quarters · filed 2025-02-28 | $269.30M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $73.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $141.50M derived: sum of 2 quarters · filed 2025-02-28 | $203.90M derived: sum of 3 quarters · filed 2025-02-28 | $252.40M 10-K · filed 2025-02-28 | ||||
| 2022-10-01 | $67.90M 10-Q · filed 2023-11-07 | $130.30M derived: sum of 2 quarters · filed 2023-11-07 | $178.80M 10-Q · filed 2023-11-07 | $229.80M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-02 | $62.40M 10-Q · filed 2023-08-08 | $110.90M 10-Q · filed 2023-08-08 | $161.90M derived: sum of 3 quarters · filed 2024-02-27 | $214.10M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-04-02 | $48.50M 10-Q · filed 2023-05-09 | $99.50M derived: sum of 2 quarters · filed 2024-02-27 | $151.70M derived: sum of 3 quarters · filed 2024-02-27 | $205.10M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $103.20M derived: sum of 2 quarters · filed 2024-02-27 | $156.60M derived: sum of 3 quarters · filed 2024-02-27 | $210.00M 10-K · filed 2024-02-27 | ||||
| 2021-10-02 | $52.20M 10-Q · filed 2022-11-08 | $105.60M derived: sum of 2 quarters · filed 2022-11-08 | $159.00M 10-Q · filed 2022-11-08 | $213.50M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | $53.40M 10-Q · filed 2022-08-09 | $106.60M 10-Q · filed 2022-08-09 | $161.30M derived: sum of 3 quarters · filed 2023-02-28 | $214.60M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | $53.20M 10-Q · filed 2022-05-11 | $107.90M derived: sum of 2 quarters · filed 2023-02-28 | $161.20M derived: sum of 3 quarters · filed 2023-02-28 | $212.80M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $54.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $108.00M derived: sum of 2 quarters · filed 2023-02-28 | $159.60M derived: sum of 3 quarters · filed 2023-02-28 | $212.20M 10-K · filed 2023-02-28 | $294.70M 10-K · filed 2021-03-01 | |||
| 2020-09-26 | $53.30M 10-Q · filed 2021-11-12 | $73.90M 10-Q · filed 2020-11-05 | $104.90M derived: sum of 2 quarters · filed 2021-11-12 | $157.50M 10-Q · filed 2021-11-12 | $219.30M 10-Q · filed 2020-11-05 | $149.40M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-27 | $51.60M 10-Q · filed 2021-08-11 | $72.20M 10-Q · filed 2020-08-05 | $104.20M 10-Q · filed 2021-08-11 | $145.40M 10-Q · filed 2020-08-05 | $96.10M derived: sum of 3 quarters · filed 2022-03-01 | $174.80M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-28 | $52.60M 10-Q · filed 2021-05-12 | $73.10M 10-Q · filed 2020-05-05 | $44.50M derived: sum of 2 quarters · filed 2022-03-01 | $123.20M derived: sum of 3 quarters · filed 2022-03-01 | $196.80M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $70.60M derived: sum of 2 quarters · filed 2022-03-01 | $144.20M derived: sum of 3 quarters · filed 2022-03-01 | $219.60M 10-K · filed 2022-03-01 | $305.50M 10-K · filed 2020-02-27 | |||
| 2019-09-28 | $78.70M 10-Q · filed 2020-11-05 | $152.30M derived: sum of 2 quarters · filed 2020-11-05 | $227.70M 10-Q · filed 2020-11-05 | $304.50M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-29 | $73.60M 10-Q · filed 2020-08-05 | $149.00M 10-Q · filed 2020-08-05 | $225.80M derived: sum of 3 quarters · filed 2021-03-01 | $310.10M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-30 | $75.40M 10-Q · filed 2020-05-05 | $152.20M derived: sum of 2 quarters · filed 2021-03-01 | $236.50M derived: sum of 3 quarters · filed 2021-03-01 | $321.80M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $76.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $161.10M derived: sum of 2 quarters · filed 2021-03-01 | $246.40M derived: sum of 3 quarters · filed 2021-03-01 | $333.60M 10-K · filed 2021-03-01 | ||||
| 2018-09-29 | $84.30M 10-Q · filed 2019-11-06 | $169.60M derived: sum of 2 quarters · filed 2019-11-06 | $256.80M 10-Q · filed 2019-11-06 | $345.10M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $85.30M 10-Q · filed 2019-08-08 | $172.40M 10-Q · filed 2019-08-08 | $260.80M derived: sum of 3 quarters · filed 2020-02-27 | $349.30M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $87.20M 10-Q · filed 2019-05-09 | $175.50M derived: sum of 2 quarters · filed 2020-02-27 | $264.00M derived: sum of 3 quarters · filed 2020-02-27 | $351.20M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $88.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $176.80M derived: sum of 2 quarters · filed 2020-02-27 | $264.00M derived: sum of 3 quarters · filed 2020-02-27 | $349.60M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $88.50M 10-Q · filed 2018-11-08 | $175.70M derived: sum of 2 quarters · filed 2018-11-08 | $261.30M 10-Q · filed 2018-11-08 | $354.10M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-07-01 | $87.20M 10-Q · filed 2018-08-09 | $172.80M 10-Q · filed 2018-08-09 | $265.60M derived: sum of 3 quarters · filed 2019-02-27 | $355.30M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-04-01 | $85.50M 10-Q · filed 2018-05-08 | $178.40M derived: sum of 2 quarters · filed 2019-02-27 | $268.10M derived: sum of 3 quarters · filed 2019-02-27 | $357.00M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $92.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $182.60M derived: sum of 2 quarters · filed 2019-02-27 | $271.50M derived: sum of 3 quarters · filed 2019-02-27 | $356.80M 10-K · filed 2019-02-27 | ||||
| 2016-10-01 | $89.70M 10-Q · filed 2017-11-09 | $162.10M 10-Q · filed 2016-11-10 | $178.60M derived: sum of 2 quarters · filed 2017-11-09 | $263.90M 10-Q · filed 2017-11-09 | $481.80M 10-Q · filed 2016-11-10 | $317.50M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-07-02 | $88.90M 10-Q · filed 2017-08-10 | $161.70M 10-Q · filed 2016-08-10 | $174.10M 10-Q · filed 2017-08-10 | $319.70M 10-Q · filed 2016-08-10 | $227.80M derived: sum of 3 quarters · filed 2018-03-01 | $302.80M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-04-02 | $85.30M 10-Q · filed 2017-05-30 | $158.00M 10-Q · filed 2016-05-16 | $138.90M derived: sum of 2 quarters · filed 2018-03-01 | $213.90M derived: sum of 3 quarters · filed 2018-03-01 | $284.00M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $53.60M derived: 10-K 6 month − 10-Q/A 3 month · filed 2018-03-01 | $128.60M 10-K · filed 2018-03-01 | $274.10M 10-KT · filed 2016-02-25 | $198.70M derived: sum of 3 quarters · filed 2018-03-01 | $233.90M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-09-26 | $75.00M 10-Q/A · filed 2017-05-23 | $147.60M 10-Q · filed 2015-11-02 | $145.10M derived: sum of 2 quarters · filed 2017-05-23 | $180.40M 10-Q/A · filed 2017-05-23 | $397.90M 10-Q · filed 2016-11-10 | $287.90M derived: sum of 4 quarters · filed 2017-05-23 | ||
| 2015-06-27 | $70.10M 10-Q/A · filed 2017-05-22 | $142.60M 10-Q · filed 2016-08-10 | $105.30M 10-Q/A · filed 2017-05-22 | $250.40M 10-Q · filed 2016-08-10 | $212.90M derived: sum of 3 quarters · filed 2017-05-22 | $174.50M 10-K · filed 2018-03-01 | $464.50M 10-K · filed 2015-08-13 | |
| 2015-03-28 | $35.20M 10-Q/A · filed 2017-05-22 | $107.80M 10-Q · filed 2015-04-29 | $142.80M derived: sum of 2 quarters · filed 2017-05-22 | $321.90M 10-Q · filed 2015-04-29 | $196.40M derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2014-12-27 | $107.60M 10-Q · filed 2015-02-05 | $214.20M 10-Q · filed 2015-02-05 | $161.20M derived: sum of 3 quarters · filed 2017-05-22 | $268.60M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-09-27 | $106.50M 10-Q · filed 2015-11-02 | $53.60M derived: sum of 2 quarters · filed 2017-05-22 | $161.00M derived: sum of 3 quarters · filed 2017-05-22 | $204.80M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-06-28 | -$52.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $54.50M derived: sum of 2 quarters · filed 2017-05-22 | $98.30M derived: sum of 3 quarters · filed 2017-05-22 | $128.20M 10-K · filed 2017-05-22 | $281.00M 10-K · filed 2014-08-14 | |||
| 2014-03-29 | $107.40M 10-Q · filed 2015-04-29 | $151.20M derived: sum of 2 quarters · filed 2015-04-29 | $181.10M 10-Q · filed 2015-04-29 | $210.00M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-28 | $43.80M 10-Q · filed 2015-02-05 | $73.60M 10-Q · filed 2015-02-05 | $102.60M derived: sum of 3 quarters · filed 2016-02-25 | $127.20M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-09-28 | $29.80M 8-K · filed 2014-11-20 | $58.80M derived: sum of 2 quarters · filed 2016-02-25 | $83.40M derived: sum of 3 quarters · filed 2016-02-25 | $105.00M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-06-29 | $29.00M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $53.60M derived: sum of 2 quarters · filed 2016-02-25 | $75.20M derived: sum of 3 quarters · filed 2016-02-25 | $94.00M 10-KT · filed 2016-02-25 | ||||
| 2013-03-30 | $24.60M 10-Q · filed 2014-05-07 | $46.20M derived: sum of 2 quarters · filed 2014-05-07 | $65.00M 10-Q · filed 2014-05-07 | |||||
| 2012-12-29 | $21.60M 10-Q · filed 2014-02-06 | $40.30M 10-Q · filed 2014-02-06 | ||||||
| 2012-06-30 | $74.80M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |